Henry Schein, Inc. (NASDAQ:HSIC) Shares Bought by Merit Financial Group LLC

Merit Financial Group LLC boosted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 22.8% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 28,409 shares of the company’s stock after acquiring an additional 5,272 shares during the quarter. Merit Financial Group LLC’s holdings in Henry Schein were worth $1,946,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC lifted its holdings in shares of Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after buying an additional 143 shares during the period. Guggenheim Capital LLC lifted its holdings in shares of Henry Schein by 2.5% in the 4th quarter. Guggenheim Capital LLC now owns 6,428 shares of the company’s stock valued at $445,000 after buying an additional 159 shares during the period. CIBC Asset Management Inc lifted its holdings in shares of Henry Schein by 1.0% in the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock valued at $1,235,000 after buying an additional 169 shares during the period. Metis Global Partners LLC lifted its holdings in shares of Henry Schein by 4.7% in the 4th quarter. Metis Global Partners LLC now owns 4,203 shares of the company’s stock valued at $291,000 after buying an additional 187 shares during the period. Finally, Sanctuary Advisors LLC lifted its holdings in shares of Henry Schein by 5.0% in the 4th quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company’s stock valued at $294,000 after buying an additional 203 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Price Performance

Shares of Henry Schein stock opened at $70.47 on Friday. The business has a 50 day simple moving average of $67.75 and a two-hundred day simple moving average of $71.66. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The stock has a market capitalization of $8.58 billion, a P/E ratio of 29.00, a PEG ratio of 2.13 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same quarter in the prior year, the firm earned $1.10 earnings per share. The business’s revenue was down .1% compared to the same quarter last year. As a group, analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on HSIC shares. Barrington Research decreased their price objective on Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a report on Tuesday, May 6th. UBS Group decreased their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Piper Sandler reduced their price target on Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a report on Wednesday, April 30th. Wells Fargo & Company reduced their price target on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a report on Tuesday, May 6th. Finally, Wall Street Zen cut Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $79.30.

Insider Activity

In other news, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Bradford C. Connett sold 4,036 shares of the company’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company’s stock, valued at $4,460,251.20. This trade represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.08% of the company’s stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.